Skip to content
中文产业新闻评分62Chinese source

辉瑞ritlecitinib两项非节段型白癜风III期试验达到共同主要终点

口服 JAK 接连突破,白癜风赛道热度拉满

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.